I don't believe that Nephros has much choice in the matter about putting out a PR regarding this latest action. I'm not totally up on OTC reporting requirements but I believe that this is material and needs to be disclosed. And if that be the case, I really don't belive that anything more will be said about it.
Now, how the investing public receives this information is another matter. Thursday could be very interesting as you can read many things into the action itself.